The African Programme for Onchocerciasis Control: impact on onchocercal skin disease

Summary Objectives  To assess the long‐term impact of the African Programme for Onchocerciasis Control on itching and onchocercal skin disease (OSD). Methods  Seven study sites in Cameroon, Sudan, Nigeria and Uganda participated. Two cross‐sectional surveys were conducted of communities meso‐ and hy...

Full description

Saved in:
Bibliographic Details
Published in:Tropical medicine & international health 2011-07, Vol.16 (7), p.875-883
Main Authors: Ozoh, G. A., Murdoch, M. E., Bissek, A‐C., Hagan, M., Ogbuagu, K., Shamad, M., Braide, E. I., Boussinesq, M., Noma, M. M., Murdoch, I. E., Sékétéli, A., Amazigo, U. V.
Format: Article
Language:English
Subjects:
Adult
African Programme for Onchocerciasis Control
Aged
Biological and medical sciences
Cameroon
Cross-Sectional Studies
Diseases caused by nematodes
Drug therapy
enfermedad cutánea de la oncocercosis
Female
Filariases
Filaricides - therapeutic use
General aspects
Helminthic diseases
Humans
impact
Impact analysis
impacto
Infectious diseases
Ivermectin - therapeutic use
lutte contre l’onchocercose
Lymphatic filariases
maladie cutanée onchocerquienne
Male
Medical sciences
Middle Aged
Nigeria
Odds Ratio
onchocercal skin disease
onchocerciasis
Onchocerciasis - complications
Onchocerciasis - drug therapy
Onchocercosis
Oncocercosis
Parasitic diseases
Programa Africano para el Control de la Oncocercosis (APOC)
Programme Africain de Lutte Contre l’Onchocercose (APOC)
Pruritus - parasitology
Risk Factors
Rural Population
Skin diseases
Skin Diseases, Parasitic - complications
Skin Diseases, Parasitic - drug therapy
Sudan
Uganda
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Objectives  To assess the long‐term impact of the African Programme for Onchocerciasis Control on itching and onchocercal skin disease (OSD). Methods  Seven study sites in Cameroon, Sudan, Nigeria and Uganda participated. Two cross‐sectional surveys were conducted of communities meso‐ and hyper‐endemic for onchocerciasis before and after 5 or 6 years of community‐directed treatment with ivermectin (CDTI). Individuals were asked about any general health symptoms including itching and underwent full cutaneous examinations. Onchocercal skin lesions were documented according to a standard classification. Results  Five thousand one hundred and ninety three people were examined in phase I and 5,180 people in phase II. The presence of onchocercal nodules was a strongly significant (P 
ISSN:1360-2276
1365-3156
DOI:10.1111/j.1365-3156.2011.02783.x